Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

Presentation TCT 2023

The Spectrum of Calcium in In-Stent Restenosis

Presenter: Gary Mintz

October 26, 2023

Presentation TCT 2023

Coronary Keynote Lecture: Evidence-Based Contemporary Options for Treatment of In-Stent Restenosis

Presenter: Franz Kleber

October 25, 2023

Presentation TCT 2023

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Presenter: Azeem Latib

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Presenter: Shao-Liang Chen

October 25, 2023

Presentation TCT 2023

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

Case 1: DCB for In-Stent Restenosis

Presenter: Rony Mathew

October 25, 2023

Presentation TCT 2023

TCT 813: DEB for In-stent restenosis, Size disparity and ostial lesions

Presenter: CHAKRABHAVI KESHAVAMURTHY

October 24, 2023

Presentation TCT 2023

TCT 811: Drug Eluting Balloon for Early Aggressive Neointimal Hyperplasia for Coronary Artery In-Stent Restenosis

Presenter: Parth Parikh

October 24, 2023

Presentation TCT 2023

TCT 611: Clinical Outcomes after First Episode In-Stent Restenosis (ISR) Percutaneous Coronary Intervention: Diabetics Versus Non-Diabetics

Presenter: Amit Hooda

October 24, 2023

Presentation TCT 2023

TCT 74: Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With In-stent Restenosis in Small Coronary Arteries.

Presenter: Wojciech Wanha

October 24, 2023

Presentation TCT 2023

TCT 749: Predictors of Suboptimal Stent Expansion Following Intravascular Lithotripsy for Coronary In-Stent Restenosis: Insights from Intravascular Imaging

Presenter: Keisuke Yasumura

October 24, 2023

Presentation TCT 2023

TCT 542: Risk Factors of Neoatherosclerosis 1-Year After Stent Implantation in Patients With Acute Coronary Syndrome

Presenter: Norihito Nakamura

October 24, 2023

Presentation TCT 2023

TCT 431: Comparison of the efficacy of sirolimus and paclitaxel-eluting balloon catheters in the Treatment of coronary In-Stent restenosis: the TIS-2 study.

Presenter: Leos Pleva

October 24, 2023

Presentation TCT 2023

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Presenter: Wojciech Wanha

October 24, 2023

Presentation TCT 2023

Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Presenter: Manel Sabate

October 24, 2023

Advertisement

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

TCTMD’s Top 10 Most Popular Stories for October 2023

The Spectrum of Calcium in In-Stent Restenosis

Coronary Keynote Lecture: Evidence-Based Contemporary Options for Treatment of In-Stent Restenosis

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Comparing DCBs in De Novo CAD: Drugs, Design Matter

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Case 1: DCB for In-Stent Restenosis

TCT 813: DEB for In-stent restenosis, Size disparity and ostial lesions

TCT 811: Drug Eluting Balloon for Early Aggressive Neointimal Hyperplasia for Coronary Artery In-Stent Restenosis

TCT 611: Clinical Outcomes after First Episode In-Stent Restenosis (ISR) Percutaneous Coronary Intervention: Diabetics Versus Non-Diabetics

TCT 74: Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With In-stent Restenosis in Small Coronary Arteries.

TCT 749: Predictors of Suboptimal Stent Expansion Following Intravascular Lithotripsy for Coronary In-Stent Restenosis: Insights from Intravascular Imaging

TCT 542: Risk Factors of Neoatherosclerosis 1-Year After Stent Implantation in Patients With Acute Coronary Syndrome

TCT 431: Comparison of the efficacy of sirolimus and paclitaxel-eluting balloon catheters in the Treatment of coronary In-Stent restenosis: the TIS-2 study.

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content